BRCA1 and breast cancer: Using transient microRNA precursor and antimiR inhibitor transfection, we studied the impact of miR-142-3p on invasiveness and cell viability in a panel of three well-established breast cancer cell lines exhibiting different degrees of dedifferentiation, different hormone receptor status, BRCA1 variant expression levels [31] and malignant potential [22, 32].